CLARK ELIANA (EVP, Chief Technical Officer) sold 0.6% of their position (607.00 shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $8.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2026ACC: 0001193125-26-088241
Officer· EVP, Chief Technical Officer
Since Feb 2022
+17.25K
Net shares
Net buyer
$8.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
17.86K acquired · 607.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.35K
Price / share
—
Trade value
—
% of position
8.4%
3/1/2026
87.12K→94.47K
Common Stock
Direct
Shares
−607.00
Price / share
$13.78
Trade value
$8.36K
% of position
0.6%
3/2/2026
94.47K→93.86K
Total
Net shares
+6.75K
Net value
-$8.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +7.35K | — | — | 8.4% | 87.12K | 94.47K |
| Common Stock Direct | 3/2/2026 | S · Sale | −607.00 | $13.78 | $8.36K | 0.6% | 94.47K | 93.86K |
| Total | +6.75K | -$8.36K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
10.51K shares
Shares
+10.51K
Strike price
13.78
Held after
10.51K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10.51K shares | 3/1/2026 | A · Award | +10.51K | 13.78 | — | 10.51K |